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Long-term oxygen therapy (LTOT) in patients with chronic hypoxaemia is an expanding field. Traditional 
stationary oxygen, with and without portable compressed gas cylinders, and portable liquid oxygen equipment is 
available today. No official guidelines exist for the prescription of liquid oxygen vs traditional oxygen supply in 
LTOT, although it is generally thought that patients receiving liquid oxygen are younger and less seriously affected. 
The authors tested this hypothesis by comparing register data from two national Scandinavian registers of patients 
on LTOT in the same time period; one including all the patients on traditional oxygen treatment alone, e.g. 
concentrators and compressed gas cylinders (n=1039), the other including all the patients using portable liquid 
oxygen alone (n = 117). 
About 80% of the patients in both groups suffered from chronic obstructive pulmonary disease. Younger patients 
were found in the liquid oxygen group (P<O.O04), but with clinically slightly worse blood gas derangement (mostly 
statistically significant). They had higher frequency of previous or present oedema (P<O.OOOl), and there were more 
smokers in this group (P<O.OOOl). No significant differences were seen with respect to sex distribution or oxygen 
delivery systems. 
Higher oxygen dose and longer daily oxygen treatment (P<O.OOOl) were prescribed for the liquid oxygen patients 
compared with the patients on traditional oxygen with statistically higher oxygen tension during the prescribed 
treatment. A slight further increase in PaCO, was seen in both groups during oxygen treatment, of doubtful 
significance. 
Compared with patients on traditional oxygen, liquid oxygen thus appears to be prescribed for younger patients, 
independent of clinical status or blood gas levels. 
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Introduction 
Long-term oxygen therapy (LTOT) is the only medical 
treatment which has shown improved survival in patients 
with chronic obstructive lung disease (COLD) with hypox- 
aemia (1,2). In other respiratory conditions leading to 
hypoxaemia, the effect of LTOT is currently not proven by 
controlled randomized trials (3-5). 
In Scandinavia, high-pressure compressed gas cylinders 
and, more recently, stationary oxygen concentrators have 
been the traditional sources available for domestic oxygen 
therapy for these patients. 
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In Sweden, a register including all the patients on LTOT 
was set up in 1987 (6). Liquid oxygen or lightweight gas 
cylinders were not available at that time. The register was 
updated on 30 June 1992 (7). 
Liquid oxygen has been available in Norway since 1990. 
The equipment is lightweight and portable, weighing as 
little as 2.5 kg and lasting up to 15-20 h when using 
O,-saving devices. Liquid 0, treatment is, however, con- 
siderably more expensive than treatment with 0, concen- 
trators (5,8,9), and its features and ambulatory use may 
impose an additional burden on the patient. 
In Norway, a register for patients on LTOT using tra- 
ditional equipment does not exist. However, a register for 
patients using liquid oxygen alone was created in January 
1993. The register was based on the previously established 
Swedish register. This means that in Norway, both tra- 
ditional and liquid oxygen was available for patients, while 
in Sweden, only traditional oxygen was available. 
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TABLE 1. Patient characteristics 
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Liquid oxygen Traditional oxygen 
(n=117) (n= 1039) P 
Age at start of treatment (years) 63.9 SD 9 66.7 SD 10 0.004 
Males 50% 47% ns 
Smokers 11% 2% ~0~0001 
Oedema 61% 49% <0~0001 
ns, not significant. 
No clear criteria exist for the use of liquid oxygen vs 
traditional stationary oxygen in patients in need of LTOT. 
It might be expected, however, that younger patients with 
less serious disease would be selected for such treatment. 
Therefore, the authors wanted to use register data from 
two different populations with regard to patient demo- 
graphics, diagnosis, blood gas status and oxygen treatment, 
to test this hypothesis. 
Patients and Methods 
The indications for LTOT for the patients in both registers 
were the internationally accepted general criteria (6,9), i.e. 
the patients should have COLD or other diseases leading to 
chronic hypoxaemia with an arterial PaO, of below 7.3 kPa 
on breathing air. The stability should be addressed during 
a 3-week period with optimum medical therapy. With 
signs or symptoms of hypoxaemia such as polycythemia, 
oedema or car pulmonale, the limit for PaO, was set at 
below 8 kPa. A minimum period of oxygen use was set 
at 15-18 h daily. 
Two national registers were used for the study. They were 
approved by their respective national Medical Control 
Authority, the Central Data Inspection Board, and the 
Regional Ethics Committees. Informed consent was 
obtained from each patient. 
The organization of the Swedish Oxygen Register and the 
results from this register have been published previously 
(4,6,7,10). In this analysis, all patients registered on 30 
June 1992 and using traditional oxygen equipment were 
included. With very few exceptions, the oxygen treat- 
ment was started and followed regularly by physicians at 
respiratory clinics. 
Cooperation between the Norwegian and Swedish 
Lung Associations allowed the authors to use the original 
Swedish record forms as a model for the Norwegian 
questionnaire. 
As stated above, both liquid and traditional oxygen 
systems were available in Norway. Liquid oxygen is only 
prescribed by chest physicians, mainly at hospitals and/or 
outpatient clinics. The oxygen is paid for by the Govern- 
ment, so economic factors do not influence the choice of 
oxygen for the particular patient. 
The Norwegian register included all patients using LTOT 
with liquid oxygen on 1 January 1993, the first patient being 
selected for liquid oxygen treatment in August 1990. 
A standard record form with 34 questions was sent to all 
chest physicians and to all hospitals with lung departments/ 
sections (total 29 centres). One key physician at each place 
was responsible for registering and completing the record 
form for patients using liquid oxygen on 1 January 1993. 
These forms contained information about age, sex, diag- 
nosis, occupation, smoking habits, medication, clinical 
signs, arterial blood gas tensions when breathing air and 
prescribed oxygen, administration of oxygen, oxygen 
requirement, job situation and level of care, i.e. living at 
home, or in institution. 
Several diagnoses causing hypoxaemia could be 
registered for the same patient. 
Information from 14 centres which prescribed liquid 
oxygen was obtained. Control lists from official district 
offices and oxygen companies verified the patients, and no 
other patients on liquid oxygen were identified. Therefore, 
the authors are confident that this register includes every 
patient on liquid oxygen in Norway on 1 January 1993. 
The data from the Norwegian register was then com- 
pared with the Swedish register updated on 30 June 1992. 
Data processing was performed using SPSS for 
Windows, version 6.0. A t-test and x2 test were used to 
compare the difference between the treatment populations. 
A level of P10.05 was considered statistically significant. 
Results 
PATIENTS 
On 1 January 1993, the Norwegian Liquid Oxygen Register 
comprised 117 patients. A comparison with the Swedish 
Oxygen Register on 30 June 1992 (n= 1039) is made in 
Tables l-4. 
Table 1 shows that patients on liquid oxygen were, as a 
mean, 3 years younger, with similar sex distribution. The 
group had significant higher occurrence of previous or 
recent oedema (Table 1). Eleven percent of the patients in 
the liquid oxygen group were still smokers, while only 
slightly above 2% in the traditional group claimed they 
were still smoking. 
In Table 2, the most common different diagnoses leading 
to hypoxaemia are compared. There was a preponderance 
of patients with COLD (near 80%) in both groups. Sequela 
from pulmonary tuberculosis, lung fibrosis, thorax deform- 
ities and pulmonary vessel disease were equally distributed 
in the two populations. 
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TABLE 2. Diagnosis 
Liquid oxygen 
(n=117) 
COLD 92/l 15 80% 
Not COLD, 23/l 15 20% 
Sequelae pulmonary tuberculosis 16 14% 
Interstitial fibrosis 12 10% 
Thoracic deformity 18 16% 
Pulmonary vessel disease 1 1% 
ns, not significant. 
TABLE 3. Arterial blood gas tensions (mean f 1 SD in kPa) 
Traditional oxygen 
(n= 1039) 
79211039 76% 
24911039 24% 
142 14% 
86 8% 
128 12% 
30 3% 
P 
ns 
ns 
ns 
ns 
ns 
PaO, without 0, 
PaCO, without 0, 
PaO, with 0, 
PaCO, with 0, 
ns, not significant. 
TABLE 4. Oxygen therapy 
Liquid oxygen 
(n=117) 
6.6 f 1.0 
6.8 zt 1.4 
9.6 f 1.7 
7.0 f 1.4 
Traditional oxygen 
(n = 1039) 
6.7 f 1.0 
6.4 zt 1.2 
9.1 A 1.3 
6.7 + 1.2 
P 
ns 
0.0008 
0~0001 
0.01 
Double nasal cann. 
Single nasal cann. 
Prescribed 0, (1 min - ‘) 
Prescribed 0, (h day - ‘) 
ns, not significant. 
Liquid oxygen Traditional oxygen 
(n=117) (n= 1039) 
108012 96% 95211039 92% 
3/112 3% 6811039 7% 
1.9 SD 0.8 1.5 SD 0.8 
20.5 SD 3.8 18.0 SD 3.5 
P 
ns 
ns 
~0~0001 
<0~0001 
Table 3 shows slightly lower PaO, (n.s.) and somewhat 
higher PaCO, (P=O.OOOS) on air breathing in the liquid 
oxygen group than in the traditional group. 
During oxygen treatment, a higher oxygen tension was 
achieved in the liquid oxygen group than in the traditional 
group, without significant further CO, retention, while the 
traditional group showed some tendency for CO,-retention 
(P<O.OOOl), although the absolute level of PaCO, was well 
below the other group. 
OXYGEN THERAPY 
All Norwegian patients in the register used portable liquid 
oxygen. In the Swedish register, oxygen concentrators were 
used by the majority of the patients (11); the remaining 
patients used stationary compressed gas cylinders. About 
47% of these had mobile oxygen equipment, but not liquid 
oxygen and not lightweight gas cylinders of Vagabond 
system. 
The patients using liquid oxygen were prescribed a higher 
oxygen flow (1.9 vs 1.5 1 min- ‘) and longer daily treatment 
period (20.5 vs 18.0 h day - i) than the traditional group 
(P<O.OOOl) (Table 4). 
The oxygen was supplied via double nasal cannulae in the 
vast majority of cases in both populations. One patient on 
liquid oxygen had tracheostoma, and in the traditional 
group, other ways of delivery were by transtracheal method 
or by mask. 
Discussion 
The authors used data from two different Scandinavian 
registers for this study. They are neighbour countries, and 
the populations are quite similar. Both registers cover about 
the same time period, thus it is felt that no major faults are 
made by retrospective comparison of the registers, and 
differences between them are described. 
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It was found that patients with chronic hypoxaemia using 
portable liquid oxygen were younger, but had slightly more 
deranged blood gases than the patients using concentrators 
and/or compressed gas cylinders. They had higher fre- 
quency of previous or present oedema, and many more 
were still smoking compared with patients in the traditional 
group. Significant differences were also observed with 
respect to the prescribed oxygen therapy and the resulting 
blood gases. 
The same severe degree of hypoxaemia occurred in both 
populations. This is in accordance with findings of no 
difference in activity measured in terms of job activity (4% 
of the patients were job active) or level of care (96% living 
at home, 3% living in institutions other than hospital) 
obtained from the Norwegian register and the Swedish 
register from 1987, as well as one updated in 1995. Unfor- 
tunately this information is not obtained in the register 
from 1992, and is therefore not included in the present 
results. 
What then are the guidelines for doctors prescribing 
liquid oxygen? Probably are younger patients, even with the 
same or worse degree of blood gas derangement, more 
mobile, and thus better suited for ambulant oxygen treat- 
ment. Also, technical difficulties with the liquid oxygen 
system might influence the physicians in selecting younger 
patients with better compliance for such treatment. 
The difference in prescribed oxygen treatment (h day - ‘) 
might be due to the lightweight portable equipment which 
probably makes it easier for the patient to comply with a 
longer oxygen treatment time than the traditional, more 
stationary equipment. 
The prescribed oxygen dose (1 min - ‘) was somewhat 
higher in the liquid oxygen group, with a concomitant 
increase in arterial oxygen tension, but without any statis- 
tically significant further CO, retention. This might be due 
to deliberate ordination by the prescribing chest physician, 
in an attempt to keep the oxygen tension at an optimum 
level even during physical activity, where the tension quite 
often falls considerably. 
In fact, most of these patients are instructed to increase 
their oxygen dose during physical activity, according to the 
results of exercise tests at the hospital or outpatient clinic. 
The traditional group showed a slight, but statistically 
significant, increase in CO, tension during the prescribed 
oxygen treatment. This could be due to a further loss of 
normal respiratory drive with increased hypoxaemic drive 
in these patients, compared with the patients on liquid 
oxygen. The blood gases in the liquid oxygen group, 
however, do not support this view as the liquid oxygen 
patients have the same degree of hypoxaemia, without 
statistically significant further CO,-retention on even higher 
oxygen supply. 
Also, the absolute level of PaCO, in the traditional group 
is significantly lower than in the liquid oxygen group. 
Further, the changes are small, so the authors feel that no 
clear conclusions should be drawn from these findings. 
The fact that 11% of the patients on LTOT with liquid 
oxygen were still smokers makes one wonder how seriously 
the prescribing doctors stress the importance of stopping 
smoking for their patients, with respect to their disease and 
to the danger of fire associated with oxygen treatment. The 
low numbers of smokers in the Swedish population is most 
probably due to the strict attitude of Swedish doctors not to 
prescribe oxygen for smokers. 
It is concluded that the main factor for the physicians 
for choosing liquid oxygen vs traditional oxygen for 
LTOT appears to be younger patients. Clinical cardiopul- 
monary status and blood gas levels do not seem to be the 
deciding factors. 
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